Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
about
Epigenetics Offer New Horizons for Colorectal Cancer PreventionInsulin-like growth factors in the gastrointestinal tract and liverHypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosisAlcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.Biology of colorectal cancer.High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stageLoss of imprinting of IGF2 and the epigenetic progenitor model of cancerMolecular mechanisms of genomic imprinting and clinical implications for cancer.Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.Multiple gene-specific DNA methylation in blood leukocytes and colorectal cancer risk: a case-control study in China.IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.RTL1 promotes melanoma proliferation by regulating Wnt/β-catenin signalling.Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.
P2860
Q22252606-C1245F41-2FF9-4DB8-AA68-974DECE9C248Q26998926-1A7CBBE7-9337-4F4E-BB18-9090CB1A4B23Q34372543-848566B5-E141-4F68-96D3-AEA3541F1A43Q34511282-93B1A955-58C5-4777-89E6-A1C093E83296Q34669618-4784AAA0-36CD-43CB-A670-46F4B4A5B2FDQ35283649-A2D63407-C01D-4063-BE0E-1A5EB92E55F9Q36813932-20104B09-1989-4845-BC01-0DA731649FBBQ37831991-309896D6-10F8-454E-AEAC-19D11450023DQ38785704-2C3479C2-4246-4E58-A1DA-FB7EB689079BQ42365268-446F085F-F065-4195-8D6A-FAC52CEDC1A2Q45895946-ABAE602E-1361-4C89-B2AE-8EE1D64423D1Q46873887-D7F9B5C1-52E9-4048-B308-ECEB98E47666Q47891968-3D6EE56C-0F93-4B13-BEA0-13C5189084F7Q51650705-DCC35009-933F-4F62-AD9B-05CE5FBCFA05Q53125923-0C887466-48A0-4201-95FF-5B5AF09E7D96
P2860
Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Loss of imprinting and marked ...... pression in colorectal cancer.
@ast
Loss of imprinting and marked ...... pression in colorectal cancer.
@en
type
label
Loss of imprinting and marked ...... pression in colorectal cancer.
@ast
Loss of imprinting and marked ...... pression in colorectal cancer.
@en
prefLabel
Loss of imprinting and marked ...... pression in colorectal cancer.
@ast
Loss of imprinting and marked ...... pression in colorectal cancer.
@en
P2093
P2860
P356
P1476
Loss of imprinting and marked ...... pression in colorectal cancer.
@en
P2093
Francis Barany
Kamran Idrees
Philip Paty
Richard Shattock
Sajid A Khan
Yu-Wei Cheng
Zhaoshi Zeng
P2860
P304
P356
10.1002/IJC.25086
P577
2010-08-01T00:00:00Z